Ole Vang
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Genomics, phytochemicals, and oxidative stress 13
- Glutathione Transferases and Polymorphisms 5
- Coenzyme Q10 studies and effects 4
-
- Sirtuins and Resveratrol in Medicine 10
- Co-authors
- Christine Bonnesen (5 shared papers)Ulrik Stervbo (2 shared papers)Joseph A. Baur (3 shared papers)Jørgen Clausen (3 shared papers)Herman Autrup (4 shared papers)Morten A. Kall (2 shared papers)Ole Andersen (6 shared papers)James M. Smoliga (1 shared paper)
- Journals
- Annals of the New York Academy of Sciences (4 papers)Carcinogenesis (3 papers)Cancer Letters (2 papers)Chemico-Biological Interactions (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- DenmarkUnited StatesVietnam
In The Last Decade
Ole Vang
51 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 109
- Geriatrics and Gerontology 343
- Biochemistry 185
- Aging 48
- Pharmacology 150
- Toxicology 52
Countries citing papers authored by Ole Vang
This map shows the geographic impact of Ole Vang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Vang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Vang more than expected).
Fields of papers citing papers by Ole Vang
This network shows the impact of papers produced by Ole Vang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Vang. The network helps show where Ole Vang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ole Vang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 219 | |
| 2 | 1996 | 110 | |
| 3 | 2020 | 96 | |
| 4 | 2011 | 94 | |
| 5 | 2012 | 89 | |
| 6 | 1990 | 63 | |
| 7 | 2018 | 56 | |
| 8 | 2000 | 56 | |
| 9 | 1991 | 53 | |
| 10 | 1999 | 48 | |
| 11 | 2006 | 44 | |
| 12 | 2013 | 43 | |
| 13 | 2013 | 43 | |
| 14 | 2016 | 38 | |
| 15 | 2015 | 37 | |
| 16 | 2013 | 36 | |
| 17 | 2013 | 36 | |
| 18 | 2009 | 33 | |
| 19 | 2000 | 32 | |
| 20 | 2010 | 31 |
About Ole Vang
Ole Vang is a scholar working on Molecular Biology, Geriatrics and Gerontology, Pharmacology, Organic Chemistry and Plant Science, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (13 papers), Sirtuins and Resveratrol in Medicine (10 papers), Pharmacogenetics and Drug Metabolism (7 papers), Glutathione Transferases and Polymorphisms (5 papers), Coenzyme Q10 studies and effects (4 papers), GABA and Rice Research (3 papers), Adipose Tissue and Metabolism (3 papers) and Biochemical effects in animals (3 papers). The work is most often cited by research in Geriatrics and Gerontology (343 citations), Biochemistry (185 citations), Aging (48 citations), Pharmacology (150 citations) and Toxicology (52 citations). Ole Vang has collaborated with scholars based in Denmark, United States and Vietnam. Frequent co-authors include Christine Bonnesen, Ulrik Stervbo, Joseph A. Baur, Jørgen Clausen, Herman Autrup, Morten A. Kall, Ole Andersen, James M. Smoliga, Randall J. Ruch and Fritz Duus. Their work appears in journals such as Annals of the New York Academy of Sciences, Carcinogenesis, Cancer Letters, Chemico-Biological Interactions and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.